Screener
Black Diamond Therapeutics, Inc. BDTX Q4 2025 Annual earnings
Reported March 16, 2026 · Before market open
EPS-$0.14Beat by $0.04
Revenue estimate$9.4M
EPS estimate-$0.18
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$8.3M
EPS estimate-$0.06
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Black Diamond Therapeutics, Inc. report Q4 2025 earnings?
- Black Diamond Therapeutics, Inc. (BDTX) reported Q4 2025 earnings on March 16, 2026 before market open.
- What were Black Diamond Therapeutics, Inc.'s Q4 2025 revenue and EPS?
- Black Diamond Therapeutics, Inc. reported eps of $-0.14 for Q4 2025.
- Did Black Diamond Therapeutics, Inc. beat estimates in Q4 2025?
- EPS beat the consensus estimate of $-0.18 by $0.04.
- How did Black Diamond Therapeutics, Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 50.0% from $-0.28.
- Where can I find Black Diamond Therapeutics, Inc.'s Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001701541-26-000008) and the 10-K periodic report (0001701541-26-000009) directly on SEC EDGAR. The filing index links above go to sec.gov.
